The NIH has awarded a $3.9 million grant to Children's Hospital Boston to develop a therapy for Fanconi anemia, a rare genetic blood disorder. Researchers at the hospital will try to turn samples of a patient's skin or tissue into induced pluripotent stem cells that can function as normal blood cells.

Related Summaries